Entropy Technologies »

BioCryst Pharmaceuticals shares owned by Entropy Technologies

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Entropy Technologies from 13F filings

Historical chart of Entropy Technologies investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Entropy Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Entropy Technologies

Quarter filed Position value Share count Share price at filing
2025-09-30 $513k 68k 7.59
2025-06-30 $184k 21k 8.96

More positions owned by Entropy Technologies

Micron Technology (MU)
Chevron Corporation (CVX)
Visa Cl A Ord Com Cl A (V)
Wal-Mart Stores (WMT)
Coca-Cola Company (KO)
Booking Holdings (BKNG)
Honeywell International (HON)
Marsh & McLennan Companies (MMC)
American Tower Reit (AMT)
Comcast Cl A Ord Cl A (CMCSA)
Fiserv (FI)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Welltower Inc Com reit (WELL)
AutoZone (AZO)

View all positions for Entropy Technologies

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals